IPC-klasse
Fullmektig i Norge:
Org.nummer: 982702887
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2009.11.03, US 257463 P
2009.11.03, US 257465 P
2010.04.22, US 327094 P
2010.04.30, US 330124 P
2010.10.18, US 394181 P
ANDRESEN ET AL: "Effect of 5 Days Linaclotide on Transit and Bowel Function in Females With Constipation-Predominant Irritable Bowel Syndrome", GASTROENTEROLOGY, ELSEVIER, PHILADELPHIA, PA, vol. 133, no. 3, 1 September 2007 (2007-09-01), pages 761-768, XP022246622, ISSN: 0016-5085, DOI: DOI:10.1053/J.GASTRO.2007.06.067 (B1)
CARSON R T ET AL: "Effect of Linaclotide on Quality of Life in Adults With Chronic Constipation: Results From 2 Randomized, Double-Blind, Placebo-Controlled Phase III Trials", GASTROENTEROLOGY, ELSEVIER, PHILADELPHIA, PA, vol. 139, no. 1, 1 July 2010 (2010-07-01), page E19, XP027202951, ISSN: 0016-5085 [retrieved on 2010-07-01] (B1)
HARRIS L A ET AL: "Drug evaluation:Linaclotide, a new direction in the treatment of irritable bowel syndrome and chronic constipation", CURRENT OPINION IN MOLECULAR THERAPEUTICS, CURRENT DRUGS, LONDON, GB, vol. 9, no. 4, 1 August 2007 (2007-08-01), pages 403-410, XP008097427, ISSN: 1464-8431 (B1)
JOHNSTON J M ET AL: "Pilot study on the effect of linaclotide in patients with chronic constipation", AMERICAN JOURNAL OF GASTROENTEROLOGY 2009 NATURE PUBLISHING GROUP GBR LNKD- DOI:10.1038/AJG.2008.59, vol. 104, no. 1, January 2009 (2009-01), pages 125-132, XP009149330, ISSN: 0002-9270 (B1)
JOHNSTON J M ET AL: "T1817 Results From the Randomized Withdrawal Period of a Phase 3 Clinical Trial of Linaclotide in Chronic Constipation", GASTROENTEROLOGY, ELSEVIER, AMSTERDAM, NL, vol. 138, no. 5, 1 May 2010 (2010-05-01), pages S-585, XP027025221, ISSN: 0016-5085 [retrieved on 2010-04-27] (B1)
WO-A2-2010/019266 (B1)
LAVINS B J ET AL: "418 Effect of Linaclotide On Quality of Life in Adults with Chronic Constipation: Results from a Phase 2B Study", GASTROENTEROLOGY, ELSEVIER, PHILADELPHIA, PA, vol. 136, no. 5, 1 May 2009 (2009-05-01), pages A-71, XP026110867, ISSN: 0016-5085, DOI: DOI:10.1016/S0016-5085(09)60320-6 [retrieved on 2009-05-01] (B1)
LEMBO A J ET AL: "157 Effect of Linaclotide On IBS-C Symptoms in the First Week of Treatment: Results from a Phase 2B Study", GASTROENTEROLOGY, ELSEVIER, PHILADELPHIA, PA, vol. 136, no. 5, 1 May 2009 (2009-05-01), pages A-30, XP026110687, ISSN: 0016-5085, DOI: DOI:10.1016/S0016-5085(09)60140-2 [retrieved on 2009-05-01] (B1)
LEMBO A J ET AL: "Linaclotide Significantly Improved Bowel Habits and Relieved Abdominal Symptoms in Adults with Chronic Constipation: Data from a Large 4-Week, Randomized, Double-Blind, Placebo-Controlled Study", GASTROENTEROLOGY, ELSEVIER, PHILADELPHIA, PA, vol. 135, no. 1, 1 July 2008 (2008-07-01), page 295, XP022823131, ISSN: 0016-5085, DOI: DOI:10.1053/J.GASTRO.2008.05.062 [retrieved on 2008-07-01] (B1)
VIOLA ANDRESEN ET AL: "Linaclotide Acetate", DRUGS OF THE FUTURE, vol. 33, no. 7, 1 January 2008 (2008-01-01), pages 570-576, XP002576431, ISSN: 0377-8282, DOI: DOI:10.1358/DOF.2008.033.07.1214164 (B1)
JOHNSTON J M ET AL: "T1817 Results From the Randomized Withdrawal Period of a Phase 3 Clinical Trial of Linaclotide in Chronic Constipation", GASTROENTEROLOGY, ELSEVIER, PHILADELPHIA, PA, vol. 138, no. 5, 1 May 2010 (2010-05-01), pages S-585, XP027025221, ISSN: 0016-5085 [retrieved on 2010-04-27] (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
Patent opphørt | Ikke betalt årsavgift |
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Opphørt for ikke betalt årsavgift (3206)
|
Utgående
EP Påminnelse om ikke betalt årsavgift (3331) (PTEP2521561)
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210)
|
Innkommende
Korrespondanse (Hovedbrev inn)
|
Utgående
EP defect letter
|
Innkommende
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 8. avg. år (EP) | 2017.11.09 | 2550 | CPA GLOBAL LIMITED | Betalt og godkjent |
31717261 expand_more expand_less | 2017.11.02 | 5500 | Zacco Norway AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|